Thomas Dietz

Insider Reports History

Entity
Individual
Location
C/O Transcept Pharmaceutical, Inc., 1003 W. Cutting Blvd, Ste 110, Pt. Richmond, CA
Signature
/s/ Douglas E. Onsi as attorney-in-fact for Thomas Dietz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Dietz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K Mar 1, 2023 Direct
LEAP THERAPEUTICS, INC. Director Stock Option (Right to Buy) 30K Oct 2, 2024 Direct
Paratek Pharmaceuticals, Inc. Director Common Stock 0 $2.20 Sep 21, 2023 Direct
Paratek Pharmaceuticals, Inc. Director Stock option (right to buy) 0 Sep 21, 2023 Direct

Insider Reports Filed by Thomas Dietz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPTX LEAP THERAPEUTICS, INC. Oct 2, 2024 1 $0 4 Oct 4, 2024 Director
LPTX LEAP THERAPEUTICS, INC. Jan 29, 2024 1 $0 4 Jan 31, 2024 Director
PRTK Paratek Pharmaceuticals, Inc. Sep 21, 2023 9 $0 4 Sep 21, 2023 Director
LPTX LEAP THERAPEUTICS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 Director
LPTX LEAP THERAPEUTICS, INC. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
PRTK Paratek Pharmaceuticals, Inc. Feb 8, 2023 1 $0 4 Feb 9, 2023 Director
EIGR Eiger BioPharmaceuticals, Inc. Jan 23, 2023 1 $71.6K 4 Jan 25, 2023 Director
EIGR Eiger BioPharmaceuticals, Inc. Dec 22, 2022 1 -$26.3K 4 Dec 27, 2022 Director
LPTX LEAP THERAPEUTICS, INC. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director
PRTK Paratek Pharmaceuticals, Inc. Feb 16, 2022 1 $0 4 Feb 18, 2022 Director
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 Director